NCT02041247 - Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2016

Conditions

HIV

Interventions

BIOLOGICAL

VAC-3S

VAC-3S is administered via intra-muscular route in the arm.

Trial Locations (12)

Hôpital Gui de Chauliac, Montpellier

Jürgen Rockstroh, Bonn

Gerd Fätkenheuer, Cologne

Hôpital de la Croix Rousse, Lyon

Hôpital Saint-Antoine, Paris

Hôpital Pitié Salpêtrière, Paris

Hôpital Cochin Saint Vincent de Paul, Paris

Hôpital Européen Georges Pompidou, Paris

Hôpital Bichat - Claude Bernard, Paris

Hôpital Tenon, Paris

Hôpital Sud Francilien, Corbeil-Essonne

Hospital Clinic University of Barcelona, Barcelona